Company Filing History:
Years Active: 2002-2006
Title: The Innovative Contributions of Elisabet De Ramon Amat
Introduction
Elisabet De Ramon Amat is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic and analgesic agents. With a total of three patents to her name, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of her latest patents involves thiazolidinedione derivatives as antidiabetic agents. This invention refers to compounds of a specific general formula, along with their possible pharmaceutically acceptable salts and tautomeric forms. The patent also outlines a process for their production and their use as antidiabetic and hypoglycemic agents, either alone or in combination with other antidiabetic agents, such as sulfonylureas or biguanides. Additionally, it addresses the treatment of complications associated with insulin resistance, including hypertension and other cardiovascular or metabolic conditions related to diabetes.
Another significant patent focuses on esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. This invention presents new esters that are analogs to tramadol, detailing a process for their production and their use in creating a medicament with analgesic properties. These new compounds exhibit an analgesic activity that surpasses that of tramadol, showcasing the potential for improved pain management solutions.
Career Highlights
Elisabet De Ramon Amat is currently associated with Vita-Invest S.A., where she continues to innovate and develop new pharmaceutical solutions. Her work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Throughout her career, Elisabet has collaborated with notable colleagues, including Marisabel Mourelle Mancini and Juan Carlos Del Castillo Nieto. These collaborations have likely contributed to the success and development of her innovative projects.
Conclusion
Elisabet De Ramon Amat's contributions to the field of pharmaceuticals through her patents demonstrate her dedication to innovation and improving healthcare. Her work in developing new antidiabetic and analgesic agents holds promise for better treatment options in the medical community.